ATE325809T1 - Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure - Google Patents

Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure

Info

Publication number
ATE325809T1
ATE325809T1 AT01943442T AT01943442T ATE325809T1 AT E325809 T1 ATE325809 T1 AT E325809T1 AT 01943442 T AT01943442 T AT 01943442T AT 01943442 T AT01943442 T AT 01943442T AT E325809 T1 ATE325809 T1 AT E325809T1
Authority
AT
Austria
Prior art keywords
amino
pentoric
leucyl
tert
hydroxy
Prior art date
Application number
AT01943442T
Other languages
English (en)
Inventor
Pascal Furet
Carlos Garcia-Echeverria
Patricia Imbach
Marc Lang
Johann Zimmermann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE325809T1 publication Critical patent/ATE325809T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01943442T 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure ATE325809T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012795.1A GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds

Publications (1)

Publication Number Publication Date
ATE325809T1 true ATE325809T1 (de) 2006-06-15

Family

ID=9892401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943442T ATE325809T1 (de) 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure

Country Status (11)

Country Link
US (2) US20030166572A1 (de)
EP (1) EP1290012B1 (de)
JP (1) JP2003533541A (de)
AT (1) ATE325809T1 (de)
AU (1) AU2001266019A1 (de)
CA (1) CA2405871A1 (de)
DE (1) DE60119514T2 (de)
ES (1) ES2261422T3 (de)
GB (1) GB0012795D0 (de)
PT (1) PT1290012E (de)
WO (1) WO2001089282A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004050609A1 (en) * 2002-11-27 2004-06-17 Elan Pharmaceutical, Inc. Substituted ureas and carbamates
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
US7919468B2 (en) 2005-04-07 2011-04-05 Centre National De La Recherche Scientifique (C.N.R.S.) Compounds useful as modulators of the proteasome activity
AU2009218456A1 (en) * 2008-02-28 2009-09-03 Novartis Ag Combination comprising a cannabinoid receptor binding compound and an opioid
EP3021120A1 (de) 2009-02-20 2016-05-18 Michael P. Lisanti Verfahren zur diagnose oder prognose eines neoplasmas einschliesslich der bestimmung des expressionsgrads eines proteins in stromazellen neben dem neoplasma
GB2523211B (en) 2012-01-27 2020-03-18 Univ Jefferson MCT protein inhibitor-related prognostic and therapeutic methods
WO2014172627A1 (en) 2013-04-19 2014-10-23 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide
KR20210016545A (ko) * 2018-05-29 2021-02-16 오메로스 코포레이션 Masp-2 억제제 및 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
EP0982317A1 (de) * 1998-08-26 2000-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalente Proteasome Inhibitore
AU4555800A (en) * 1999-04-27 2000-11-10 Novartis Ag Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors

Also Published As

Publication number Publication date
JP2003533541A (ja) 2003-11-11
WO2001089282A3 (en) 2002-05-10
CA2405871A1 (en) 2001-11-29
GB0012795D0 (en) 2000-07-19
US20060205673A1 (en) 2006-09-14
DE60119514D1 (de) 2006-06-14
EP1290012A2 (de) 2003-03-12
DE60119514T2 (de) 2006-10-05
PT1290012E (pt) 2006-09-29
AU2001266019A1 (en) 2001-12-03
WO2001089282A2 (en) 2001-11-29
ES2261422T3 (es) 2006-11-16
US20030166572A1 (en) 2003-09-04
EP1290012B1 (de) 2006-05-10

Similar Documents

Publication Publication Date Title
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
DE60144392D1 (de) Antivirale mittel
SE0101387D0 (sv) Novel compounds
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
MXPA04000577A (es) Derivados de dolastatina 10.
PT1404347E (pt) Nucleosidos 4'-substituidos para o tratamento de doencas mediadas pelo virus da hepatite c
ATE361287T1 (de) Neue indol-2-on derivate
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
PT1041072E (pt) Acidos dioxociclopentil hidroxamicos
CY1108871T1 (el) Υποκατεστημενα παραγωγα αμινο-φουραν-2-υλ-οξεικου οξεος και αμινο-θειεν-2-οξεικου οξεος και η χρησιμοποιηση τους για τη θεραπεια ημικρανιας ή πονου
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
DE60045508D1 (de) Dalda-analoge und ihre verwendung
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
SE0302139D0 (sv) Novel compounds
DE60001586D1 (de) Diphenyl-piperidin derivate
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE9804212D0 (sv) Compounds
MXPA05010020A (es) Derivados de oxamida.
ATE267816T1 (de) Tan-1057 derivate
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
ATE517626T1 (de) Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
ATE440835T1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1290012

Country of ref document: EP

REN Ceased due to non-payment of the annual fee